Clinical Trial Update: 123I-mIBG SPECT Imaging [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on 123I-mIBG SPECT imaging for heart failure and coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure

Drugs mentioned

• [123I]-MIBG (Iodine-123 labeled MIBG (123I-MIBG))

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Heart Failure, Coronary Artery Disease | Phase 3 | Status: COMPLETED